Cash Flow Statement
Growth Metrics

Harvard Bioscience (HBIO) Other Non-Current Assets (2010 - 2026)

Harvard Bioscience (HBIO) reported Other Non-Current Assets of $2.6 million for Q1 2026, down 26.59% year-over-year from $3.5 million in Q1 2025, and down 3.98% on a QoQ basis from $2.7 million in Q4 2025.

Harvard Bioscience (HBIO) has 17 years of Other Non-Current Assets data on file, last reported at $2.6 million in Q1 2026.

  • Quarterly Other Non-Current Assets fell 26.59% year-over-year to $2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (down 26.59% YoY) and the FY2025 annual result came in at $2.7 million, down 5.08% from the prior year.
  • Other Non-Current Assets retreated to $2.6 million in Q1 2026 per HBIO's latest filing, from $2.7 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $8.7 million in Q2 2022 and bottomed at $2.3 million in Q3 2024.
  • The 5-year median for Other Non-Current Assets is $4.8 million (2024), against an average of $5.2 million.
  • The widest annual swing landed in 2022, when Other Non-Current Assets soared 1047.24%; it then sank 69.39% in 2024.
  • Tracing HBIO's Other Non-Current Assets over 5 years: stood at $7.8 million in 2022, then dropped by 16.8% to $6.5 million in 2023, then sank by 56.23% to $2.8 million in 2024, then decreased by 5.08% to $2.7 million in 2025, then dropped by 3.98% to $2.6 million in 2026.
  • Per Business Quant, the three latest HBIO Other Non-Current Assets figures stand at $2.6 million (Q1 2026), $2.7 million (Q4 2025), and $3.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn -
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 2.43 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 210.73 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 81.30 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 848.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 688.40 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 39.83 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 692.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 159.52 Mn
10 Harvard Bioscience 25.38 Mn 18.29 Mn 12.24 Mn 2.58 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.58 Mn
Dec 31, 2025 2.69 Mn
Sep 30, 2025 3.79 Mn
Jun 30, 2025 3.79 Mn
Mar 31, 2025 3.52 Mn
Dec 31, 2024 2.83 Mn
Sep 30, 2024 2.30 Mn
Jun 30, 2024 3.24 Mn
Mar 31, 2024 4.79 Mn
Dec 31, 2023 6.47 Mn
Sep 30, 2023 7.51 Mn
Jun 30, 2023 6.41 Mn
Mar 31, 2023 7.94 Mn
Dec 31, 2022 7.78 Mn
Sep 30, 2022 8.31 Mn
Jun 30, 2022 8.69 Mn
Mar 31, 2022 5.26 Mn
Dec 31, 2021 5.38 Mn
Sep 30, 2021 724,000.00
Jun 30, 2021 810,000.00
Mar 31, 2021 812,000.00
Dec 31, 2020 1.09 Mn
Sep 30, 2020 1.90 Mn
Jun 30, 2020 1.74 Mn
Mar 31, 2020 1.88 Mn
Dec 31, 2019 2.27 Mn
Sep 30, 2019 320,000.00
Jun 30, 2019 191,000.00
Mar 31, 2019 1.25 Mn
Dec 31, 2018 1.82 Mn
Sep 30, 2018 1.79 Mn
Mar 31, 2018 1.35 Mn
Dec 31, 2017 9.96 Mn
Sep 30, 2017 121,000.00
Jun 30, 2017 131,000.00
Mar 31, 2017 144,000.00
Dec 31, 2016 -104,000.00
Sep 30, 2016 112,000.00
Jun 30, 2016 94,000.00
Mar 31, 2016 132,000.00
Dec 31, 2015 152,000.00
Sep 30, 2015 349,000.00
Jun 30, 2015 406,000.00
Mar 31, 2015 352,000.00
Dec 31, 2014 380,000.00
Sep 30, 2014 359,000.00
Jun 30, 2014 378,000.00
Mar 31, 2014 292,000.00
Dec 31, 2013 316,000.00
Sep 30, 2013 346,000.00
Jun 30, 2013 371,000.00
Mar 31, 2013 818,000.00
Dec 31, 2012 490,000.00
Sep 30, 2012 67,000.00
Jun 30, 2012 110,000.00
Mar 31, 2012 163,000.00
Dec 31, 2011 215,000.00
Sep 30, 2011 246,000.00
Jun 30, 2011 286,000.00
Dec 31, 2010 360,000.00